Some meds are not linked to birth defects. Pregnant moms who are
worried about the effects of taking antidepressants can breathe a little
easier. Women who take selective serotonin reuptake inhibitors (SSRIs),
such as Prozac, Zoloft, Paxil and Lexa-Pro, are no more likely to have
babies with birth defects.
By
Colin Allen, published on April 01, 2003
Pregnant moms who are worried about the effects of taking
antidepressants can breathe a little easier. Women who take selective
serotonin reuptake inhibitors (SSRIs), such as Prozac, Zoloft, Paxil and
Lexa-Pro, are no more likely to have babies with birth defects.
Victoria Hendrick, M.D., from the University of California at Los
Angeles followed 138 non-smoking women, between the ages of 24 and 44. In
the study, 85 women were taking SSRIs at the beginning of pregnancy; the
rest started medication during pregnancy. She found that these women did
not put their children in jeopardy for congenital defects, premature
birth or low birth rate. Among these women, there was a 1.4 percent
chance of a defect; this figure is equivalent to that of the general
population.
Researchers, however, still conclude that it is best for pregnant
mothers to minimize their exposure to antidepressants. Three women in the
study who were taking high levels of Prozac--40 to 80 milligrams-- had
low-birthweight babies. It is unclear if the SSRIs or depression itself
was the cause. Also reports of jitteriness and rapid breathing in
newborns may be caused by antidepressants. Hendrick recommends that
pregnant women use fewer antidepressants. She suggests non-pharmaceutical
alternatives such as therapy or group counseling.
The study was published in the
American Journal of Obstetrics and
Gynecology.
For more on antidepressants
click here.
Tags:
american journal of obstetrics,
american journal of obstetrics and gynecology,
congenital defects,
hendrick,
jitteriness,
journal of obstetrics,
journal of obstetrics and gynecology,
lexa pro,
low birth rate,
low birthweight babies,
obstetrics and gynecology,
pharmaceutical alternatives,
pregnant moms,
pregnant mothers,
rapid breathing,
serotonin reuptake inhibitors,
smoking women,
university of california at los angeles